All Blogs

Oct 21, 2020

In today’s healthcare system quality care, rising cost, and satisfaction are significant issues that need to be addressed to improve the experience of patients. To provide an alternative to these issues a new health-care model called Value-based healthcare or VBC is gaining significant attention from industry leade...

Oct 20, 2020

Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia   The US FDA has granted its full approval to Venclexta (venetoclax) for newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older who are unfit for intensive induction chemotherapies.  The approval is based on the res...

Oct 19, 2020

Neurodegenerative diseases affect millions of people worldwide. And with the world demographics getting older, it is apt to foretell that the burden of neurodegenerative disorders is expected to mount. With advances in medical technology, the life expectancy of people has drastically increased, reeling people to an...

Aug 14, 2024

Breast cancer is the most common form of cancer in women. Each year, it affects over 2 million women globally and is the most significant cause of death among women. Among the many types of breast cancer, a particularly formidable foe is Triple-negative breast cancer (TNBC), which accounts for 10-20% of all cases. ...

Oct 15, 2020

Cyclerion flunks sickle cell test, prompting pivot to CNS disease Cyclerion Therapeutics has terminated the development of olinciguat in sickle cell disease after getting a look at data from a phase 2 trial. The setback caused Cyclerion to switch its focus to IW-6463 and to treat central nervous system diseases....

Oct 14, 2020

The disparity can be any type of imbalance or inequality that brings various types of variation in society, based on age, education, income, gender, etc. In a society, a wide number of disparities exist; disparities in wealth, living styles, resources, and several different aspects of society. However, the disparit...

Oct 13, 2020

U.S., AstraZeneca strikes an antibody treatment USD 486 million deal The U.S. government awarded the pharma giant AstraZeneca a sum of USD 486 million for the development of up to 100,000 corona vaccine doses. The deal, under Operation Warp Speed, will people the manufacturing of antibody doses and facilitate th...

Oct 12, 2020

After 40 years of the introduction of the BCG immunotherapy, it continues to remain as the gold standard of the treatment of Non-muscle invasive bladder cancer (NMIBC). However, BCG intravesical therapy fails to yield responses in more than 50% of the NMIBC patients. After a shocking failure of BCG, cystectomy is p...

Jun 30, 2025

Schizophrenia, a term introduced over a century ago, continues to perplex clinicians and researchers alike. Characterized by hallucinations, delusions, disorganized thinking, and cognitive decline, it remains one of the most debilitating and misunderstood psychiatric conditions. Affecting approximately 20 million p...

Oct 08, 2020

Designing a universal flu vaccine by focusing on the immune system  A universal flu vaccine that can foster protection to people against any influenza strain is considered a goal in flu research as it could spare scientists from the often erroneous process of predicting the circulating strains each year and...